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Abstract
Helicobacter pylori isolation in fecal samples is a less invasive and more comfortable 
practice than those that require patient endoscopy, particularly in children. However, 
culture of this pathogen from stools is usually unsuccessful. Other techniques such as PCR 
or H. pylori Stool Antigen (HpSA) are used to detect the presence of H. pylori in feces; 
nevertheless, a positive result by using these techniques does not involve viability of the 
pathogen. Direct Viable Count combined with Fluorescent in situ Hybridization (DVC-
FISH) technique has been successfully applied to detect viable H. pylori cells in highly 
contaminated environmental samples. To assess the suitability of DVC-FISH technique 
to identify viable H. pylori cells in stools, experimentally inoculated feces and fecal 
samples from infected patients were analyzed. qPCR and culture techniques were also 
used. Viable H. pylori cells were detected by DVC-FISH in all inoculated samples with 
a specific DNA/LNA probe. H. pylori colonies were also identified on agar. DVC-FISH 
gave positive results in all the patients’ fecal samples, while qPCR only detected  H. 
pylori in two patients. 
DVC-FISH technique with LNA/DNA probes has the potential to be used as a 
specific and effective non-invasive method for the detection of viable H. pylori in stools 
samples. Moreover, our results evidence the presence of viable H. pylori cells in fecal 
samples from infected patients, supporting the evidence that H. pylori is transmitted 
via the fecal route.
INTRODUCTION
H. pylori is the cause one of the most common chronic 
infections in humans [1]. It is estimated that approximately 50% 
of the world population is infected; however, only about 10-15% 
of infected individuals will develop peptic ulcer, and in 1-3% 
gastric cancer will appear.
Currently a range of techniques are being applied for 
diagnosis, each with their own advantages and disadvantages. 
Invasive gastroscopic biopsy-based methods, such as the Rapid 
Urease Test (RUT), histological examination and culture have 
been widely used to diagnose H. pylori infection [2]. Endoscopy 
is an expensive procedure, not free of risks, that requires highly 
qualified personnel to be carried out. It is also an uncomfortable 
procedure, especially in non-collaborative patients and children. 
Other non-invasive diagnostic techniques, urea breath test 
(UBT), stool antigen detection or serology, are also widely used. 
However, these present some problems, such as being technically 
demanding, presenting non-optimun specificity or difficulty 
in assessing the existence of an active infection [3]. Moreover, 
they do not allow for isolating the bacteria. Thus, no antibiotic 
resistance tests or genetic characterization can be performed. 
Bacteriological culture is a tedious, time-consuming procedure, 
and unnecessary for the routine diagnosis of H. pylori infection 
in the majority of patients. The sensitivity of culture has been 
reported to vary greatly among laboratories, because H. pylori is 
very fastidious, and even experienced laboratories recover it 
from only from 50% to 70% of infected biopsies [4]. However, 
culture is the most specific way to diagnose H. pylori infection. It 
allows for testing of the antibiotic sensitivity of isolated strains, 
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enables us to have a better understanding of the pathogen-host 
interaction and facilitates to determine the main epidemiologic 
features relative to this pathogen [4]. Especially, culture from 
clinical or environmental samples is crucial to demonstrate the 
potential of this sample to act as a transmission vehicle, as the 
bacterium must be present in a viable form to be infective.
There is much controversy regarding the transmission 
pathways of H. pylori [5]. Different routes have been proposed, 
such as oral-oral, fecal-oral and indirect transmission via water 
or even foods. H. pylori have been found in feces, saliva or vomit 
[4] and may even be acquired through other routes [6]. 
Among all the transmission mechanisms, fecal-oral 
transmission seems to be one of the most relevant, especially in 
developing countries, as suggested by different epidemiological 
studies [7]. H. pylori, present in gastric mucosa, is constantly 
eliminated to the gut via gastric juice. Thus, feces or any material 
contaminated by them, such as water, vegetables or milk, could 
be the vehicle of transmission for the infection [8]. 
The existence of a fecal-oral route means that the bacterium 
should be isolated from stool specimens. Extensive indirect 
evidence suggests that the organism is present in feces. Momtaz 
et al. [9] detected H. pylori in different areas of the digestive tract 
(10, 72% in saliva, 77, 66% in gastric biopsies and 71, 67% in 
feces). By PCR, H. pylori DNA has been detected it in fecal samples 
[4]. Equally H. pylori Stool Antigen (HpSA) test supports the view 
that H. pylori is excreted in the feces. Even so, there is still the 
doubt about how H. pylori can remain viable. The bacterium is 
sensitive to bile, so it should not be able to survive during its 
transit through the enteric tract [10]. 
A positive result obtained by PCR or antigen tests does not 
mean that the pathogen maintains its viability in the feces, as it 
may just be that they are detecting the antigen or DNA from dead 
bacteria. Therefore, except for some reports of culture from the 
stool, there is little evidence that H. pylori survives in the colon. 
Attempts to culture H. pylori from feces have had limited 
success. Recovery from stool is very difficult because of the 
complex nature of the sample: stools are rich in bile salts, 
hydrolytic enzymes [11] and other commensal biota hampering 
the growth of H. pylori [2]. It may also be possible that the 
bacterium is viable but not culturable (VBNC) due to the stressful 
environmental conditions during its passage along the intestinal 
tract. 
The use of sensible and specific methods for detecting viable 
cells of H. pylori in feces could be an alternative to invasive 
diagnostic methods, particularly for children, as feces can be 
comfortably obtained at home and without active collaboration 
[12]. Moreover, these techniques could facilitate epidemiological 
studies about its mode of transmission.
Direct Viable Count combined with Fluorescent in situ 
Hybridization (DVC-FISH) has been previously used to detect 
and identify viable H. pylori cells in water samples [13] and it can 
be easily applied to feces. Thus, the objective of this work was 
to assess the suitability of DVC-FISH technique to detect and 
identify viable H. pylori cells in fecal samples. HpSA, qPCR and 
culture techniques were also used for comparison.
MATERIAL AND METHODS
Helicobacter pylori Strains
H. pylori NCTC 11637 and B67 (isolated from a gastric human 
biopsy) strains were used for inoculation assays. Bacteria were 
grown on Columbia agar plates (Difco Laboratories, Detroit, 
MI, USA) supplemented with 10% horse blood, Dent selective 
supplement (Oxoid) and 0.0025% sodium pyruvate, at 37oC 
under microaerobic conditions. 
Inoculated faecal samples
Exponential (48 h) cultures of both H. pylori strains were used 
to spike H. pylori-free faecal samples. Briefly, cultures from both 
NCTC 11637 and B67 strains were resuspended in PBS buffer 
(130 mmol/L sodium chloride, 10 mmol/L sodium phosphate, 
pH 7.2), diluted to give 107-108 CFU/mL, and used to inoculate 1 g 
of feces mixed previously with 9 mL of PBS. Samples were shaken 
for 5 min at 160 rpm to enable bacteria to attach to fecal particles. 
One mL aliquots of each inoculated sample were taken for later 
processing by q-PCR and DVC-FISH. One hundred µl samples 
were also spread onto Dent selective agar. In addition, 200 µl 
were inoculated on a 0.65 µm membrane (Whatman, Maidstone, 
England) and placed onto selective agar. Plates were incubated 
at 37 ° C under microaerobic conditions. After 24 h incubation, 
membranes of the plates were removed and incubated further 
for 48 -72h. Presumptive colonies were identified by FISH and 
qPCR as described below.
q-PCR
DNA from 1 mL sample was isolated by using the GeneJetTM 
Genomic DNA Purification kit (Fermentas, Germany) according 
to the manufacturer´s instructions.
Two µl of the eluted DNA was used for specific H. pylori SYBR 
Green-based qPCR with VacA primers, described previously, [14] 
to amplify a 372-bp fragment from the vacA gene of H. pylori [14]. 
Real time was performed in a final volume of 20 µl containing: 4 
µl of LightCycler Fast-Star DNA Master SYBR Green I (Light Cycler 
Fast Start DNA Master SYBR Green I. Roche Applied Science.), 1.6 
µl of MgCl2 (4mM), 0.5 µl of each primer and 2 µl of template. 
The amplification consisted of an initial DNA denaturation step at 
95ºC for 10 minutes, followed by a 40-cycle reaction: 95ºC for 10 
seconds, 62ºC for 5 seconds, 72ºC for 16 seconds and after that 
one cycle of extension at 72ºC for 15 seconds and finally one cycle 
at 40ºC for 30 seconds. 
PCR products were visualized under 1.5 % agarose gel 
electrophoresis stained with 0.01% GelRed (Biotium, USA)and 
then purified with the GenElute PCR Clean-Up Kit (Sigma, USA) 
according to manufacturer’s instructions and subsequently 
analyzed by sequencing (IBMCP, CSIC). The homology of the 
amplified sequences with the correspondent H. pylori vacA gene 
fragment was determined by a BLAST alignment (www.ncbi.nlm.
nih.gov/BLAST).
DVC-FISH analysis
One mL of sample was inoculated in 9mL of DVC broth 
(Brucella broth supplemented with 5% Fetal Bovine Serum (FBS) 
and 0.5 mg/L novobiocin) supplemented with 0.0025% sodium 
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piruvate and incubated for 24 hours under optimal conditions for 
H. pylori [15].
After incubation, DVC tubes were centrifuged at 8500 rpm 
for 8 minutes. The supernatant was removed and the pellet was 
resuspended in 1 mL of PBS 1X and then fixed for FISH analysis as 
described for Gram-negative bacteria by Moreno et al. [16]
The fixed samples were deposited on the wells of hybridization 
slides, air dried and dehidrated by successive immersing in 
volumes of 50, 80 and 100 % ethanol for 3 minutes each. Fixed 
samples were subsequently hybridized with LNA- HPY and 
EUB 338 16S rRNA probes labelled with CY3 and fluoresce in 
respectively, according to conditions described by Moreno et 
al. Briefly, hybridization buffer (0.9 M/L NaCl , 0.01 % SDS, 20 
mM/L Tris-HCl and 40 % formamide, pH 7.6) containing 50 ng 
of each probe were deposited on the wells and then, slides were 
incubated at 46ºC for 2 h in darkness. After washing, hybridized 
samples were examined with an Olympus microscope BX50 
equipped with a 100W mercury high-pressure bulb and set 
filters U-MWB, U-MWIB and U-MWIG. Color micrographs were 
taken with a digital camera Olympus DP 12 (Olympus Optical Co., 
Hamburg, Germany). The fluorescent green intensity signal was 
measured with Olympus DP Soft program.
Faecal samples
Outpatients sent to the Endoscopy Unit of the Hospital de 
Sabadell for evaluation of dyspeptic symptoms were recruited 
for the study. Patients were contacted prior to the endoscopy, 
and asked to participate. Those who agreed signed informed 
consent. Patients were instructed to avoid antisecretory drugs 
during the two weeks before the test and they were asked to 
bring a faecal sample on the day the endoscopy was performed. 
Before the endoscopy, a 13[C]-urea breath test (UBT) (UBiTest 
100 mg, Otsuka Pharmaceutical Europe Ltd, UK) was performed. 
During endoscopy, two antral biopsies for histology and one for 
rapid urease test (RUT, JATROX HP test CHR Heim Arzneimittel 
GmbH, Germany) were obtained. A total of 5 faecal samples from 
infected patients (positive for all tests above described) were also 
analysed to test the suitability of DVC-FISH technique in order to 
identify viable H. pylori.
Five grams of fresh faeces were homogenized with 45mL 
of PBS buffer and vortexed. One mL aliquots were processed 
for DVC-FISH and qPCR as previously described for inoculated 
samples. One hundred µL was also analysed directly by culture 
on Dent agar under the above describe conditions and 400µL 
were placed onto a 0.65 µm cellulose acetate membrane filters 
and deposited on selective agar media as previously described 
[13]. Samples were also analysed after an enrichment step. 
Briefly, 10 mL of the homogenized samples were suspended in 20 
mL of Dent enrichment broth and incubated under microaerobic 
conditions at 37ºC for 24 h. After enrichment, aliquots were 
obtained for further analysis by DVC-FISH, qPCR and culture as 
for non- enriched samples.
RESULTS AND DISCUSSION
Histology is one of the most common tests used to detect the 
H. pylori infection and is considered by most authors the “gold 
standard” [17]. Nevertheless, it is also an invasive and expensive 
screening technique. Helicobacter pylori detection in faecal 
samples is an easier and more comfortable practice than invasive 
techniques, mainly in children. However, culture of this pathogen 
from stools is difficult and normally unsuccessful, and colonies 
confirmation tests are necessary. Other techniques such as PCR 
or H. pylori Stool Antigen (HpSA) are used to detect the presence 
of H. pylori in faeces. Nevertheless, a positive result by these 
techniques does not recognise the viability of the pathogen. This 
is an important point, as transmission of the bacteria via fecal-
oral route, although generally admitted, is not fully assessed, 
due mainly to our lack of knowledge about the cellular state and 
infectiveness of H. pylori in feces.
In this work we have improved the specific method DVC-
FISH to use as a non-invasive method to detect the pathogen in 
infected individuals. 
Presumptive H. pylori colonies were observed from both 
NCTC 11637 and B67 inoculated samples, but in all cases with 
a high nonspecific microbiota growth on agar plates (Figure 1) 
Colonies from inoculated faeces were only appreciated on the 
plates in which the samples were passed through a membrane. 
Viable H. pylori cells were detected by DVC-FISH in all 
samples of inoculated faeces with specific DNA/LNA probe 
(Figure 2). In spite of the presence of great amount of competitive 
microbiota, viable (elongated) and non- viable H. pylori cells were 
easily observed. After enrichment, samples showed an increase 
of unspecific microbiota, hindering H. pylori identification. 
Inoculated samples were also qPCR positive directly and 
yielded negative results after enrichment. These results were 
in accordance with previous reports about H. pylori detection 
[18], showing that a previous enrichment step does not favor the 
detection of the pathogen by qPCR. 
As shown with the inoculated samples, some H. pylori 
presumptive colonies from patient fecal samples were only 
observed on the plates cultured by membrane technique in 2 out 
of 4 patients. Colonies could not be purified because of growth of 
unspecific microbiota on the selective plates. Thus, identification 
of H. pylori cells within the cultures was only possible by 
molecular methods such as qPCR and FISH. The low efficiency on 
H. pylori detection by culture could be due not only to the lack of 
specificity of culture media but also, the environmental stress on 
the pathogen through the gastro intestinal tract, which become H. 
pylori to VBNC state, diminish the pathogen recovery [11]. Other 
Figure 1 Bacterial growth on Dent selective agar plates inoculated 
with feces.
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authors have reported the difficulty to culture H. pylori from 
feces and the need for a pretreatment of the patient prior to the 
analysis in order to reduce the bile salts content [12]. 
qPCR analysis detected H. pylori in feces from 2 out of the 4 
patients, one of them after enrichment. Although qPCR is a highly 
sensitive technique, stools are complex mixtures that often 
contain PCR inhibitors and other commensal bacteria making 
false-negative and false-positive results a larger problem [19].
DVC-FISH showed the presence of viable H. pylori in all the 
patients samples according with the results obtained by invasive 
methods (histology and RUT). It seems that the factors affecting 
the cultivation of H. pylori in feces do not affect their metabolic 
activity, thus remaining viable and potentially infective. Although 
DVC-FISH is not as sensitive as other molecular techniques for 
less contaminated samples [18], it was more efficient than qPCR 
in this kind of samples. In addition, this technique incorporated 
an overview of the habitat and microbiota companion of the 
species studied, as well as morphology that adopt these bacteria 
in the feces, allowing for its count. 
Thus, DVC-FISH technique would be an effective alternative 
to culture for the detection of viable cells of H. pylori in feces. 
It is a less invasive, more comfortable practice and more cost-
effective than culture from gastric biopsy, and the results could 
be obtained in 48h, a short time with regard to culture.
Moreover, our results evidence the presence of viable H. 
pylori cells in fecal samples from infected patients, supporting the 
evidence of the fecal route of H. pylori transmission.
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